Cancer Research Aziza Shad  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 5266-5269, October 1, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wiencke, J. K.
Right arrow Articles by Petrakis, N. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wiencke, J. K.
Right arrow Articles by Petrakis, N. L.

Individual Susceptibility to Induced Chromosome Damage and Its Implications for Detecting Genotoxic Exposures in Human Populations1

John K. Wiencke2, Margaret R. Wrensch, Rei Miike and Nicholas L. Petrakis

Department of Epidemiology and Biostatistics [J. K. W., M. R. W., R. M., N. L. P.], and Laboratory of Radiobiology and Environmental Health [J. K. W.], School of Medicine, University of California, San Francisco, California 94143-0560

In a previous study, we observed a bimodal distribution of sensitivity to sister chromatid exchange (SCE) induction by diepoxybutane (DEB) in lymphocytes from healthy individuals. Twenty-four % of the participants had increased sensitivity to in vitro induction of SCEs and chromosomal aberrations. These same participants also had significantly higher frequencies of uninduced or baseline SCE frequencies. In the present study, we measured baseline and DEB-induced SCE frequencies in 55 healthy female volunteers. Eleven of 55 [20%] women were relatively sensitive to DEB induction of SCEs. Baseline SCE frequencies in these sensitive individuals [10.4 ± 0.7 (SD) SCEs/cell] were significantly higher [P < 0.001; Student's t test] than baseline SCE frequencies in the remaining 44 individuals [8.0 ± 0.9 SCEs/cell]. Similar increases in SCEs were observed when the analysis was restricted to the upper 10% of the SCE distribution (high frequency SCE analysis). The phenotype of DEB sensitivity accounted for 58% of the variation among individual SCE scores. Given the population frequency of this sensitivity to SCE induction and the high proportion of variance in SCEs for which it accounts, failure to account for this factor could seriously distort conclusions about SCE measures associated with other environmental exposures. The most likely result of such unexplained variability (type II error) would be bias toward the null hypothesis. Also, the likelihood that individual variations contribute to false positive results is expected to be greatest in studies that compare small numbers of exposed and nonexposed individuals. To summarize, these results confirm our earlier study and show that increased baseline SCE frequencies can be indicative of increased sensitivity to certain classes of mutagenic carcinogens. Identification of DEB-sensitive persons could be used to increase the sensitivity of SCE analysis in monitoring studies to detect exposure to genotoxins.

1 This work was supported in part by Grant P42-ES04705 from the National Institute of Environmental Health Sciences; by the Office of Health and Environmental Research, United States Department of Energy, Contract DE AC03-76-SF01012; and USPHS Grant PO1 CA 13556-18 from the National Cancer Institute, Bethesda, MD.

2 To whom requests for reprints should be addressed, at the Department of Epidemiology and Biostatistics, School of Medicine, University of California, San Francisco, CA 94143-0560.

Received 3/ 6/91. Accepted 7/23/91.




This article has been cited by other articles:


Home page
Cancer Res.Home page
E. J. Duell, E. A. Holly, P. M. Bracci, J. K. Wiencke, and K. T. Kelsey
A Population-based Study of the Arg399Gln Polymorphism in X-Ray Repair Cross- Complementing Group 1 (XRCC1) and Risk of Pancreatic Adenocarcinoma
Cancer Res., August 15, 2002; 62(16): 4630 - 4636.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
E. J. Duell, E. A. Holly, P. M. Bracci, M. Liu, J. K. Wiencke, and K. T. Kelsey
A Population-Based, Case-Control Study of Polymorphisms in Carcinogen-Metabolizing Genes, Smoking, and Pancreatic Adenocarcinoma Risk
J Natl Cancer Inst, February 20, 2002; 94(4): 297 - 306.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R.B. Hayes, L. Zhang, S. Yin, J.A. Swenberg, L. Xi, J. Wiencke, W.E. Bechtold, M. Yao, N. Rothman, R. Haas, et al.
Genotoxic markers among butadiene polymer workers in China
Carcinogenesis, January 1, 2000; 21(1): 55 - 62.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
M.n. Murg, M. Schuler, and D.A. Eastmond
Evaluation of micronuclei and chromosomal breakage in the 1cen-q12 region by the butadiene metabolites epoxybutene and diepoxybutane in cultured human lymphocytes
Mutagenesis, November 1, 1999; 14(6): 541 - 546.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.